The Art and Science of Drug Hunting | Christoph Lengauer, CSO & Co-Founder of Curie.bio

The Art and Science of Drug Hunting | Christoph Lengauer, CSO & Co-Founder of Curie.bio

December 10, 2025 · 1h 13m · Episode 38

About this episode

Christoph Lengauer discusses his journey in drug hunting and the philosophy behind Curie.bio's approach to drug discovery.

In this episode, we sit down with Christoph Lengauer, co-founder of Curie.Bio, a venture creation firm, and former founding CSO and Chief Drug Hunter at Blueprint Medicines. Christoph's non-linear career began in Austria as the first in his family to attend college, leading him to pursue human genetics after reading a book on cancer. Despite finding success in academia, he quit science, only to return with a focus on creating medicines, which he considers the ultimate impact. This pivot led him to the best molecular genetics cancer lab in the world, the lab of Bulgin at Johns Hopkins, where he stayed for 12 years and helped lead the lab for nine. Christoph shares his philosophy on "responsible practice" in drug discovery, a path that avoids the slow, "fat way" of big pharma and the reckless "slim way," by taking measured risks and doing only the necessary work to get to meaningful results the fastest. He argues that successful drug hunting is found in the "margin," defined by cultural elements such as being honest, humble, and transparent, and being surrounded by a supportive team, not just technical strength or intelligence. We dig into his time at Third Rock Ventures, where he…

More episodes of Nucleate Podcast

Explore listener stats, chart rankings, contacts and more on the Nucleate Podcast podcast page.